Ads
related to: drugs prescribed for rheumatoid arthritis medications brand names- Discover An RA Treatment
Still Experiencing RA Symptoms?
A Treatment Plan Change May Help.
- See Treatment Results
Help Relieve Your RA Symptoms
With A Once-Daily Oral Pill.
- Find A Rheumatologist
Find A Rheumatologist Near You.
Set Goals For RA Treatment.
- Injection-Free Treatment
RA TNF Blocker Didn't Work For You?
See How A JAK Inhibitor May Help.
- Discover An RA Treatment
Search results
Results From The WOW.Com Content Network
When used as drugs, ... Name Brand name Type Source Target Approved Use 3F8: mab: ... rheumatoid arthritis, Crohn's disease, plaque psoriasis, ...
Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.
Conventional DMARDs are known to be the first-line treatment for rheumatoid arthritis. [9] Treatment can be a monotherapy or in combination with other anti-arthritic medications. Common DMARDs include oral methotrexate, leflunomide, or sulfasalazine. Conventional DMARDs have a slow onset of action and can take 2–3 months to exhibit effect. [9]
Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469 2 Ledipasvir/sofosbuvir: Harvoni Small molecule Hepatitis C: Gilead Sciences: 13,864 11,737 3 Etanercept: Enbrel Biologic Rheumatoid arthritis: Amgen. Pfizer. 8,697 4,009 4 Infliximab ...
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
The European Medicines Agency (EMA) has approved the use of golimumab as a treatment for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. [5] [10] Golimumab was approved for the treatment by the US Food and Drug Administration (FDA) as well as the European Medicines Agency (EMA) in 2013 for the treatment of ulcerative colitis.
Ads
related to: drugs prescribed for rheumatoid arthritis medications brand names